echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Front Oncol: Risk factors for locally recurring breast cancer patients and the effect of surgical treatment

    Front Oncol: Risk factors for locally recurring breast cancer patients and the effect of surgical treatment

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Breast cancer is the most common cancer worldwide and the main cause of death from cancer in women
    .


    With a better understanding of the biological behavior of tumor, screening of innovative technologies and integrated multidisciplinary treatment strategy development, more breast cancer at an early stage diagnosis out


    Breast cancer is the most common cancer worldwide and the main cause of death from cancer in women


    The study retrospectively analyzed early breast cancer patients who underwent surgery in Ruijin Hospital affiliated to Shanghai Jiaotong University from January 2009 to March 2018
    .


    LRR is defined as recurrence in the ipsilateral breast (IBTR), chest wall, or regional lymph nodes without complicated distant metastasis (DM)


    The study retrospectively analyzed early breast cancer patients who underwent surgery in Ruijin Hospital affiliated to Shanghai Jiaotong University from January 2009 to March 2018


    A total of 5202 patients were included in the study


    After a median follow-up of 47.


    Multivariate analysis showed tumor size (p<0.


    Multivariate analysis of recurrence related factors

    Multivariate analysis of recurrence related factors

    Forty (46.
    0%) of 87 LRR patients underwent further salvage surgery
    .


    Multivariate analysis showed that the size of the primary tumor (p = 0.


    Forty (46.


    The 5-year OS rates of LRR patients, DM patients, and patients without recurrence were 80.


    Comparison of prognosis

    Comparison of prognosis

    The median follow-up time after recurrence was 21.
    3 months (range: 1.
    0-77.
    5), with 30 deaths
    .


    The PR-OS of patients with LRR as the first event was significantly better than that of DM patients (3-year PR-OS 75.


    The median follow-up time after recurrence was 21.


        Comparison of prognosis after recurrence

    Comparison of prognosis after recurrence

    Multivariate analysis showed that ER positive (HR = 0.
    33, 95% CI 0.
    12 0.
    91, p = 0.
    033) and LRR salvage surgery (HR = 0.
    11, 95% CI 0.
    02 0.
    93, p = 0.
    043) were independent of the improvement of PR-OS in LRR patients Related
    .

    Multivariate analysis showed that ER positive (HR = 0.
    33, 95% CI 0.
    12 0.
    91, p = 0.
    033) and LRR salvage surgery (HR = 0.
    11, 95% CI 0.
    02 0.
    93, p = 0.
    043) were independent of the improvement of PR-OS in LRR patients Related
    .

    In summary, studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
    .
    Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
    .

    In summary, studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
    .
    Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
    .
    Studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
    .
    Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
    .
    Studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
    .
    Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
    .

    Original source:

    Original source:

    Huang J, Tong Y, Chen X and Shen K (2021) Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients.
    Front.
    Oncol.
    11:763119.
    doi: 10.
    3389/fonc.
    2021.
    763119

    Huang J, Tong Y, Chen X and Shen K (2021) Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients.
    Front.
    Oncol.
    11:763119.
    doi: 10.
    3389/fonc.
    2021.
    763119 here message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.